SHARED VALUES. AUTHENTICITY. CHARACTER. MUMBAI, India, Aug. 15, 2026 /PRNewswire/ — Victorinox India today announced actor Abhay Deol as a…
Read MoreBusiness Micro
News Stories
77 DAYS TO GO: 7 WONDERS OF FUTURE CITIES COUNTS DOWN TO START OF VOTING
DUBAI, UAE, Aug. 15, 2026 /PRNewswire/ — 7 Wonders of Future Cities today marks 77 days until global voting begins…
Read MoreMichael Owen Joins ehamarkets as Global Brand Ambassador
HONG KONG and NEW YORK, Aug. 14, 2026 /PRNewswire/ — ehamarkets today announced a global brand partnership with England football…
Read MoreFERRERO GROUP TO ACQUIRE PURELY ELIZABETH, A LEADING U.S. MODERN WELLNESS BRAND
LUXEMBOURG and BOULDER, Colo., Aug. 14, 2026 /PRNewswire/ — Ferrero Group today announced it has signed an agreement to acquire…
Read MoreBybit TradFi Perpetuals Extend 24/7 Exposure to Over 200 Global Equities and Pre-IPO Assets
DUBAI, UAE, Aug. 14, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is pleased to announce…
Read MoreRemotePeople Completes 2026 SOC 2 Type II Audit Across Security, Availability, and Confidentiality
The New York-headquartered global Employer of Record renews its SOC 2 Type II attestation for a full 12-month period, adding…
Read MoreHippocratic AI Unveils Agentic Orchestrators: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 14, 2026 /PRNewswire/ — The New…
Read MoreFractal’s Vaidya.ai Powers BMC Health AI Chatbot on WhatsApp for Mumbai
First deployment under the MoU with BMC to pioneer integrated AI solutions spanning patient interactions, doctor support, and public health…
Read MoreBitmine Immersion Technologies Announces Record and Payment Dates for Cash Dividends on 9.50% Series A Perpetual Preferred Stock
NORWALK, Conn., Aug. 14, 2026 /PRNewswire/ — (NYSE: BMNR; BMNP) Bitmine Immersion Technologies, Inc. (“Bitmine” or the “Company”) announced today…
Read MoreArkBio’s RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial
SHANGHAI, Aug. 14, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the U.S. Food and Drug…
Read More